These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37708928)

  • 1. Therapeutic potential of lithium chloride and valproic acid against neuronopathic types of mucopolysaccharidoses through induction of the autophagy process.
    Gaffke L; Firyn N; Rintz E; Pierzynowska K; Piotrowska E; Mazur-Marzec H; Węgrzyn G
    Arch Biochem Biophys; 2023 Oct; 747():109754. PubMed ID: 37708928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular Organelle-Related Transcriptomic Profile Abnormalities in Neuronopathic Types of Mucopolysaccharidosis: A Comparison with Other Neurodegenerative Diseases.
    Wiśniewska K; Gaffke L; Żabińska M; Węgrzyn G; Pierzynowska K
    Curr Issues Mol Biol; 2024 Mar; 46(3):2678-2700. PubMed ID: 38534785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has resveratrol a potential for mucopolysaccharidosis treatment?
    Rintz E; Pierzynowska K; Podlacha M; Węgrzyn G
    Eur J Pharmacol; 2020 Dec; 888():173534. PubMed ID: 32877657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses.
    Muenzer J; Ho C; Lau H; Dant M; Fuller M; Boulos N; Dickson P; Ellinwood NM; Jones SA; Zanelli E; O'Neill C
    Mol Genet Metab; 2024 Aug; 142(4):108535. PubMed ID: 39018614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of (Poly)phenolic Antioxidants and Other Natural Autophagy Modulators in the Treatment of Sanfilippo Disease: Remarkable Efficacy of Resveratrol in Cellular and Animal Models.
    Rintz E; Podlacha M; Cyske Z; Pierzynowska K; Węgrzyn G; Gaffke L
    Neurotherapeutics; 2023 Jan; 20(1):254-271. PubMed ID: 36344724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in cellular processes occurring in mucopolysaccharidoses as underestimated pathomechanisms of these diseases.
    Gaffke L; Pierzynowska K; Podlacha M; Brokowska J; Węgrzyn G
    Cell Biol Int; 2021 Mar; 45(3):498-506. PubMed ID: 31855304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
    Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
    J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.
    Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G
    Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of genes coding for proteins involved in metabolic processes in mucopolysaccharidoses, evidenced by a transcriptomic approach.
    Pierzynowska K; Deresz P; Węgrzyn G; Gaffke L
    Metab Brain Dis; 2023 Aug; 38(6):2133-2144. PubMed ID: 37195412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein aggregation and autophagy dysfunction: new lessons from mucopolysaccharidoses.
    Monaco A; Fraldi A
    Autophagy; 2021 Nov; 17(11):3875-3876. PubMed ID: 34407725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
    Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
    Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses.
    Minami K; Morimoto H; Morioka H; Imakiire A; Kinoshita M; Yamamoto R; Hirato T; Sonoda H
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle disturbances in mucopolysaccharidoses: Transcriptomic and experimental studies on cellular models.
    Brokowska J; Gaffke L; Pierzynowska K; Cyske Z; Węgrzyn G
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1639-1649. PubMed ID: 36000158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
    De Pasquale V; Scerra G; Scarcella M; D'Agostino M; Pavone LM
    Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of genes involved in apoptosis is dysregulated in mucopolysaccharidoses as revealed by pilot transcriptomic analyses.
    Brokowska J; Pierzynowska K; Gaffke L; Rintz E; Węgrzyn G
    Cell Biol Int; 2021 Mar; 45(3):549-557. PubMed ID: 32125037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of vesicle trafficking dysregulation to the pathomechanism of mucopolysaccharidosis.
    Gaffke L; Pierzynowska K; Cyske Z; Podlacha M; Węgrzyn G
    Biochem Biophys Res Commun; 2023 Jul; 665():107-117. PubMed ID: 37149983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses.
    Baydakova G; Ilyushkina A; Gaffke L; Pierzynowska K; Bychkov I; Ługowska A; Wegrzyn G; Tylki-Szymanska A; Zakharova E
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32183018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.